Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
Punjabi to English - Standard rate: 0.06 USD per word / 15 USD per hour English to Punjabi - Standard rate: 0.06 USD per word / 15 USD per hour English to Hindi - Standard rate: 0.06 USD per word / 15 USD per hour Hindi to English - Standard rate: 0.06 USD per word / 15 USD per hour Hindi to Punjabi - Standard rate: 0.05 USD per word / 15 USD per hour
Punjabi to Hindi - Standard rate: 0.04 USD per word / 15 USD per hour
Source text - Punjabi About This Study
This is a research study to test a drug, Boceprevir (Victrelis™), which may be available
by prescription for adults in the United States. Boceprevir has been used to treat adults with Chronic Hepatitis C (CHC). Recent studies have shown that, when used as a standard of care treatment in adults, Boceprevir can suppress the virus to untraceable levels.
Peginterferon alfa-2a and Ribavirin have been approved by the United States Food and Drug Administration (FDA) for the treatment of infection with hepatitis C virus (HCV) and are available by prescription. To make it easier, we will call the combination of these two drugs "PEG2a/R".
The purpose of this study is to: test the safety and effectiveness of boceprevir in treating chronic hepatitis C virus.
compare the effectiveness of two different treatments for CHC using Boceprevir.
There may be reasons why you are not allowed to take part in this study. Some of these reasons include:
You are less than 18 years of age. You do not have previously documented CHC genotype 1 infection. You have HIV or hepatitis B.
Page 1 of 14
You have previously been treated with an interferon and ribavirin regimen or HCV direct acting anti-viral regimen.
You have had treatment for hepatitis C with any investigational medication. You have participated in any other clinical trial within 30 days of your screening
visit or intend to participate in another clinical trial during participation in this trial.
You have evidence of hepatocellular carcinoma (HCC) or are under evaluation for HCC.
You have any known malignancy (cancer or a spreading tumor) or a history of malignancy within the past 5 years.
You are pregnant, breastfeeding, or planning to become pregnant within 6 months after receiving the last dose of study drug.
Learn more about additional services I can provide my clients
Learn more about the business side of freelancing
Stay up to date on what is happening in the language industry
Transition from freelancer to agency owner
Improve my productivity
This is to introduce myself as an freelance Linguist in Hindi & Punjabi since 2009 with Punjabi as my Mother-tongue. My skills and experience position me as a strong
candidate for the role and I am confident I will help your organization both in
handling its regular workload and long-term goals.
Resume indicates that my background includes more than 10 years of service in
this industry, I would definitely provide the best services to you. Please find
the following details:
· I did Bachelor of Commerce from GNDU, Amritsar in 2005
and got 70%.
· I appeared for M.Com in 2006 from IGNOU University and got 70%.
I continued my teaching profession simultaneously while pursuing M.com.
· Observing my interest and passion for languages, Thereafter, I moved towards Translation Industry in 2009 and started my career
as a fresher. Fortunately, I got good projects from many Indian &
International clients. I worked and presently working with many renowned agencies. References can be
provided on request.
Translation, Editing, Proofreading and Back-Translation, Transcription,
Back-Translation Reconciliation,Over the phone Interpreting - Since 2009
Phone: 9914555557, 9914747777
Address: 61, NRI Colony, Phase - II,
Loharka Road, Amritsar, Punjab, India
Keywords: Native Punjabi linguist proficient in Medical, General, Banking & Insurance, Conversation
This profile has received 35 visits in the last month, from a total of 18 visitors